Test
334 articles
The Diabetes and Pancreatic Cancer Connection
Professor Dr. Suresh Chari explains the link between newly on-set diabetes as an indication of pancreatic cancer. Read Dr. Chari’s findings to learn more.
Dousing Out-of-Control KRAS Signaling in Pancreatic Cancer
Rene Bernards and his team are targeting the signaling pathway of the KRAS mutation, which occurs in almost all pancreatic cancers.
Taking a Systems Biology Approach to Find a New Pancreatic Cancer Target
Dr. Andrea Califano is using systems biology and cell regulators to find new targets in the search for ways to stop pancreatic cancer cells.
An Interview with Dr. Tyler Jacks
Dr. Tyler Jacks is one of the leading pancreatic cancer researchers. Read what he has to say about KRAS, organoids, and running a lab in a pandemic.
RNA Precision Trial for Pancreatic Cancer Opens At Columbia
Dr. Andrea Califano leads a precision oncology clinical trial of the OncoTreat platform, which looks at proteins to determine treatment.
Will New-Onset Diabetes Provide a Way to Detect Pancreatic Cancer Earlier?
Dr. Anirban Maitra, Dr. Suresh Chari, and others are looking at the relationship between new-onset diabetes and pancreatic cancer.
Two New Immunotherapy Trials Aim to Make Therapy More Effective
Two clinical trials in the Lustgarten Foundation’s Clinical Accelerator are testing different combinations of immunotherapy.
Claudin May Be the Next Big Target in Pancreatic Cancer Treatment
Dr. Wungki Park leads a trial that uses a monoclonal antibody to target a protein that is common in pancreatic cancer.
Platform Trial Design Aims to Get Information Quickly and Efficiently
Dr. Eugene Koay is leading a platform trial, for a more nimble way to adapt to participants’ response to treatments being tested.
Platform Trial Increases Efficiency in Studying Immunotherapy
Dr. Elizabeth Jaffee is betting that three types of immunotherapy will rev up the immune system and make chemotherapy more effective in a platform trial.
Slowing the Growth of One Type of Advanced Neuroendocrine Tumor
Dr. Kelsey Klute explains the advantages of the radiopharmaceutical lutetium Lu 177 dotatate treatment for certain neuroendocrine tumors.
Diabetes
If You Have Diabetes, Are You at Risk for Pancreatic Cancer? If you are living with diabetes or prediabetes, you may have heard that there is a link between diabetes and pancreatic cancer. Please be reassured that most people with diabetes do not develop pancreatic cancer. However, it is known that almost one in four […]
Share Your Story
Thank you for offering to share your treatment experience with us. Your participation reflects the true mission of Let’s Win—patients helping each other learn about treatment options that will hopefully help extend their lives. Our Survivor Stories from patients are intended to provide accessible, actionable information and hope. The form below asks some questions to […]
In Treatment
Finding a Pancreatic Cancer Specialist
Finding a Pancreatic Cancer Specialist Near You A diagnosis of pancreatic cancer can be very overwhelming. One of the first steps is to find a doctor who has experience with this cancer. Let’s Win has created a comprehensive healthcare map of pancreatic cancer specialists in the U.S., based on the number of patients a provider […]